Sunday, October 4, 2026
Home Authors Posts by Ogkologos

Ogkologos

4359 POSTS 0 COMMENTS

No OS Benefit from Continuous as Compared with Fixed-Duration Maintenance Therapy...

Ogkologos -
0

FDA Approves Allogeneic Regulatory T Cell-Based Immunotherapy with HSPC and T...

Ogkologos -
0

Combination of mFOLFOX6/Bevacizumab Plus Atezolizumab Prolongs PFS Compared with Atezolizumab in...

Ogkologos -
0

Use of YEARS Algorithm, D-dimer Levels, and Performing Risk-Dependent CT Pulmonary...

Ogkologos -
0

EMA Recommends Extension of Indications for Ponatinib Associated with a New...

Ogkologos -
0

Could Functional Precision Medicine Be the New Precision Oncology?

Ogkologos -
0

Adding Pirtobrutinib to Venetoclax-Rituximab Shows Significant Improvement in PFS Among Patients...

Ogkologos -
0

FDA Approves Sacituzumab Govitecan-hziy as Monotherapy and in Combination with Pembrolizumab...

Ogkologos -
0

Ovarian Reserve Better Indicator of Adjuvant Chemotherapy Benefit than Self-Reported Menopause...

Ogkologos -
0

Immune-Modulating SBRT Plus Anti-PD-L1 May Convert Immune-Cold ER-positive, HER2-negative EBC Into...

Ogkologos -
0
1...567...436Page 6 of 436

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com